drugset / Trial / NCT05649878
Evaluation of the Bioavailability of Methylprednisolone
RandomizedCrossoverOpen-labelOther
Summary
This study is aimed to evaluate the bioavailability of methylprednisolone in healthy subjects of both genders, with administration intranasally versus intravenous
Timeline
- Start
- 2021-11-05
- Primary completion
- 2021-11-10
- Completion
- 2021-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylprednisolone | Other / unclassified | 62.5 mg | Intravenous |
Indications
No indication recorded.